Switzerland’s Covid-19 scientific taskforce chief says hospitals across the Alpine country could be swamped with new coronavirus cases in the next two or three weeks unless the situation improves.
“We estimate that the capacity limit in intensive care in hospitals will be reached between November 5-18 if nothing changes from the current situation,” Martin Ackermann told reporters in Bern on Friday. “We don’t have time to wait any longer.”
The number of new Covid-19 cases has risen sharply in recent days. A total of 6,634 new cases – a record – were reported by the Swiss health authorities on Friday.
They confirmed that the country was now more badly affected than its neighbours: it now has 495 cases per 100,000 inhabitants. Only France approaches these levels at 450 cases per 100,000.
On Friday, Ackermann said that hospitalisations were doubling week by week. The same goes for the number of intensive care cases and deaths due to Covid-19. Over the past 14 days 689 people were hospitalised, and 75 died.
Overall, there have now been more than 100,000 cases – 103,653 cases to be precise – since the start of the epidemic and 1,877 deaths.
Contact to a minimum
He urged people to keep their contact with others to a minimum, while the head of the association of cantonal doctors asked people to avoid “delicate situations”, by keeping to social distancing and avoid risky sports and leisure activities.
Testing and tracing capacity is stretched, with officials appealing to those who test positive to personally inform people with whom they have had contact.
Ackermann told reporters that Switzerland’s containment strategy was no longer working due to the high number of cases. For the virus reproduction rate to drop below 1 again, it is necessary to reduce professional and private contacts by half, he said.
Experts have discovered what they believe is the world’s most mutated COVID strain – and there’s one detail in particular that has scientists worried. Scientists have detected what is believed to be the world’s [...]
SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists at Columbia University Vagelos [...]
ANSTO has contributed to a comprehensive investigation of a promising type of nanoparticle that could potentially be used for intractable brain cancers in a combined therapy. The study, which was led by Dr. Moeava [...]
The immune response needed to protect people against reinfection with the coronavirus will be explored in a new human challenge trial, researchers have revealed. Human challenge trials involve deliberately exposing healthy people to a [...]
Researchers from Duke University are developing a flu shot with the new technology that was used for two coronavirus vaccines. Both the Pfizer-BioNTech and the Moderna shots use part of the virus's genetic code [...]
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19. In a paper published in the journal Nanoscale, [...]
Researchers have developed a new superbug-destroying coating that could be used on wound dressings and implants to prevent and treat potentially deadly bacterial and fungal infections. The material is one of the thinnest antimicrobial [...]
The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the Centers for Disease Control [...]
The South African coronavirus variant is better at "breaking through" the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday. However, one of the authors told AFP that [...]
EPFL scientists have developed AI-powered nanosensors that let researchers track various kinds of biological molecules without disturbing them. The tiny world of biomolecules is rich in fascinating interactions between a plethora of different agents [...]
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular [...]
Researchers at Brown University have succeeded in creating the first wireless, implantable, rechargeable, long-term brain-computer interface. The wireless BCIs have been implanted in pigs and monkeys for over 13 months without issue, and human [...]
The coronavirus outbreak made household names of companies like Moderna Inc. and BioNTech SE, whose shots offered hope for ending the pandemic. Now a new wave of vaccines is on the horizon that may get the [...]
Researchers at the University of Southampton have developed a new way of using nanomaterials to identify and enrich skeletal stem cells—a discovery which could eventually lead to new treatments for major bone fractures and [...]
In March 2020, Hannu Rajaniemi pivoted his biotech company Helix Nanotechnologies' focus from cancer therapies to Covid-19 vaccines. The role biotech start-ups can play in a pandemic Rajaniemi originally co-founded Helix Nanotechnologies in Cambridge, Massachusetts in [...]
The rapid mass testing strategy costing just £1 a day per child can get children back to school and economies up and running, according to experts. That is the small price of the [...]